Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

The Food and Drug Administration (FDA) has cleared an investigational new drug application for the novel treatment, APTN-101, ...

Recovery from addiction is a journey rather than a destination. As individuals transition from addiction to sobriety, they ...

A drug currently used to treat HIV has also been found to dramatically reduce the risk of infection, significantly more than the primary option available for pre-exposure prophylaxis or PrEP.

A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...

Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to ...

The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...

Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more effective treatments. One organ receiving particular attention in this area is ...

Two senators want to empower the FDA to send warning letters to influencers and telehealth companies that publish deceptive ...

Civil society organisations opposing the patent applications of US-based pharma major Gilead ... According to UNAIDS, this new HIV drug can offer hope of ending AIDS if all have access. Lenacapavir, ...

As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than ...